Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Precursor Cell Lymphoblastic Leukemia-Lymphoma × durvalumab × 1 year × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 75 Lung Neoplasms 43 Carcinoma, Hepatocellular 37 Small Cell Lung Carcinoma 29 Biliary Tract Neoplasms 17 Cholangiocarcinoma 16 Urinary Bladder Neoplasms 15 Breast Neoplasms 15 Neoplasms 11 Liver Neoplasms 11 Squamous Cell Carcinoma of Head and Neck 10 Ovarian Neoplasms 10 Carcinoma 10 Triple Negative Breast Neoplasms 9 Pancreatic Neoplasms 8 Neoplasm Metastasis 8 Gallbladder Neoplasms 7 Esophageal Neoplasms 7 Stomach Neoplasms 6 Colorectal Neoplasms 6 Prostatic Neoplasms 5 Melanoma 5 Endometrial Neoplasms 5 Adenocarcinoma 5 Neoplasms by Site 4 Mesothelioma 4 Carcinoma, Squamous Cell 4 Carcinoma, Renal Cell 4 Adenocarcinoma Of Esophagus 4 Uterine Cervical Neoplasms 3

Interventions

Cyclophosphamide 101 fludarabine 54 Methotrexate 51 Vincristine 47 Cytarabine 47 Dexamethasone 46 fludarabine phosphate 41 blinatumomab 36 Whole-Body Irradiation 30 Mycophenolic Acid 27 Mercaptopurine 27 venetoclax 25 Tacrolimus 25 pegaspargase 24 Melphalan 24 Etoposide 23 Doxorubicin 22 Prednisone 20 Rituximab 19 Stem Cell Transplantation 18 Granulocyte Colony-Stimulating Factor 18 Daunorubicin 18 Calcium Dobesilate 18 Specimen Handling 17 Peripheral Blood Stem Cell Transplantation 17 Filgrastim 16 Busulfan 16 Asparaginase 15 Thiotepa 14 merphos 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡